UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

5-year overall survival after early breast cancer diagnosed during pregnancy: A retrospective case-control multicentre French study

European journal of cancer (1990), 2018-05, Vol.95, p.30-37

2018

Volltextzugriff (PDF)

Role of the HER2 [Ile655Val] genetic polymorphism in tumorogenesis and in the risk of trastuzumab-related cardiotoxicity

Annals of oncology, 2007-08, Vol.18 (8), p.1335-1341

2007

Volltextzugriff (PDF)

1874 Phase 1b/2 study results for masitinib plus gemcitabine and carboplatin in advanced triple negative breast cancer

European journal of cancer (1990), 2015-09, Vol.51, p.S290-S291

2015

Volltextzugriff (PDF)

2560 Baseline serum clusterin level in patients with poor prognostic features was associated with response to custirsen treatment: Results from the phase 3 SYNERGY trial of docetaxel +/- custirsen

European journal of cancer (1990), 2015-09, Vol.51, p.S497-S497

2015

Volltextzugriff (PDF)

PD-0046: Outcome according to pelvic radiotherapy in the GETUG 12 phase III trial for high-risk localized prostate cancer

Radiotherapy and oncology, 2015-04, Vol.115, p.S22-S22

2015

Volltextzugriff (PDF)

PO-1002: APBI in the elderly: 5-year results of high-dose-rate interstitial multicatheter brachytherapy

Radiotherapy and oncology, 2014, Vol.111, p.S145-S146

2014

Volltextzugriff (PDF)

5098 POSTER Prognostic Factors of Breast Cancer Brain Metastases

European journal of cancer (1990), 2011, Vol.47, p.S359-S359

2011

Volltextzugriff (PDF)

A randomized controlled phase II trial of a novel composition of paclitaxel embedded into neutral and cationic lipids targeting tumor endothelial cells in advanced triple-negative breast cancer (TNBC)

Annals of oncology, 2014-04, Vol.25 (4), p.824-831

2014

Volltextzugriff (PDF)

Endocrine therapy or chemotherapy as first-line therapy in hormone receptor–positive HER2-negative metastatic breast cancer patients

European journal of cancer (1990), 2018-05, Vol.95, p.93-101

2018

Volltextzugriff (PDF)

Expression of the hypoxia-inducible monocarboxylate transporter MCT4 is increased in triple negative breast cancer and correlates independently with clinical outcome

Biochemical and biophysical research communications, 2014-08, Vol.451 (1), p.54-61

2014

Volltextzugriff (PDF)

Paclitaxel plus bevacizumab or paclitaxel as first-line treatment for HER2-negative metastatic breast cancer in a multicenter national observational study

Annals of oncology, 2016-09, Vol.27 (9), p.1725-1732

2016

Volltextzugriff (PDF)

Local Recurrence after Breast Cancer Affects Survival Differently According to Patient Age

International journal of radiation oncology, biology, physics, 2009, Vol.75 (3), p.S184-S184

2009

Volltextzugriff (PDF)

Epidermal growth factor receptor expression in 780 breast cancer patients: A reappraisal of the prognostic value based on an eight-year median follow-up

Annals of oncology, 2001-06, Vol.12 (6), p.841-846

2001

Volltextzugriff (PDF)

What do you think about generic drugs products? Results from a survey

Clinical therapeutics, 2015-08, Vol.37 (8), p.e130-e131

2015

Volltextzugriff (PDF)

Corrigendum to “De novo metastatic breast cancer in patients with a small locoregional tumour (T1-T2/N0): characteristics and prognosis” [Eur J Cancer 158 (2021) 181–188]

European journal of cancer (1990), 2022-05, Vol.166, p.311-312

2022

Volltextzugriff (PDF)

De novo metastatic breast cancer in patients with a small locoregional tumour (T1-T2/N0): Characteristics and prognosis

European journal of cancer (1990), 2021-11, Vol.158, p.181-188

2021

Volltextzugriff (PDF)

Radio-frequency heating of the cornea: theoretical model and in vitro experiments

IEEE transactions on biomedical engineering, 2002-03, Vol.49 (3), p.196-205

2002

Volltextzugriff (PDF)

Stereotactic Pelvic Reirradiation for Locoregional Cancer Relapse

Clinical oncology (Royal College of Radiologists (Great Britain)), 2021-01, Vol.33 (1), p.e15-e21

2021

Volltextzugriff (PDF)

A personalized adjuvant treatment for women over 70 presenting with a luminal breast cancer? ASTER 70s or an ongoing phase III trial with parallel cohort by the UNICANCER GERICO and UCBG groups for an ongoing question

Journal of geriatric oncology, 2012-10, Vol.3, p.S34-S35

2012

Volltextzugriff (PDF)

Breast cancer patients treated with intrathecal therapy for leptomeningeal metastases in a large real-life database

ESMO open, 2021-06, Vol.6 (3), p.100150-100150, Article 100150

2021

Volltextzugriff (PDF)

Incidence and outcome of brain and/or leptomeningeal metastases in HER2-low metastatic breast cancer in the French ESME cohort

ESMO open, 2024-05, Vol.9 (5), p.103447-103447, Article 103447

2024

Volltextzugriff (PDF)

430 Dose finding of inecalcitol, a new VDR agonist, in combination with docetaxel–prednisone regimen for castrate-resistant prostate cancer (HRPC) patients (pts)

European journal of cancer supplements, 2010, Vol.8 (7), p.136-136

2010

Volltextzugriff (PDF)

Outcomes of 9800 metastatic luminal HER2-negative breast cancer patients in the French national real-life UNICANCER ESME-breast cohort

European journal of cancer (1990), 2018-04, Vol.92, p.S20

2018

Volltextzugriff (PDF)

102 (PB-003) - Outcomes of 9800 metastatic luminal HER2-negative breast cancer patients in the French national real-life UNICANCER ESME-breast cohort

European journal of cancer (1990), 2018-04, Vol.92, p.S20-S20

2018

Volltextzugriff (PDF)

Patritumab deruxtecan in untreated hormone receptor-positive/HER2-negative early breast cancer: final results from part A of the window-of-opportunity SOLTI TOT-HER3 pre-operative study

Annals of oncology, 2023-08, Vol.34 (8), p.670-680

2023

Volltextzugriff (PDF)

1 – 25 von 311

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(228)
Mit Volltextzugriff
(304)

Publikationsform

Artikel
(237)
Tagungsberichte
(74)

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(159)
Life Sciences & Biomedicine
(87)
Physics
(70)
Technology
(70)
Engineering
(56)
Physical Sciences
(56)
Engineering, Biomedical
(44)
Myocardium
(40)
Computer Science
(39)
Computer Simulation
(39)
Computational Modeling
(38)
Physics, Particles & Fields
(38)
High Energy Physics - Experiment
(37)
Humans
(35)
Cardiac & Cardiovascular Systems
(34)
Cardiovascular System & Cardiology
(34)
Computer Science, Interdisciplinary Applications
(32)
Ischemic Pain
(32)
Particle Physics
(32)
Physics, Nuclear
(31)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Physics Letters. B
(65)
Annals Of Oncology
(20)
Nuclear Physics. B
(15)
European Journal Of Cancer
(13)
Nuclear Physics. A
(11)
Physics Letters B
(11)
Esmo Open
(9)
Phys.Lett.B
(5)
Zeitschrift Für Physik C Particles And Fields
(4)
European Journal Of Cancer Supplements
(3)

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

5-year overall survival after early breast cancer diagnosed during pregnancy: A retrospective case-control multicentre French study

Role of the HER2 [Ile655Val] genetic polymorphism in tumorogenesis and in the risk of trastuzumab-related cardiotoxicity

1874 Phase 1b/2 study results for masitinib plus gemcitabine and carboplatin in advanced triple negative breast cancer

2560 Baseline serum clusterin level in patients with poor prognostic features was associated with response to custirsen treatment: Results from the phase 3 SYNERGY trial of docetaxel +/- custirsen

PD-0046: Outcome according to pelvic radiotherapy in the GETUG 12 phase III trial for high-risk localized prostate cancer

PO-1002: APBI in the elderly: 5-year results of high-dose-rate interstitial multicatheter brachytherapy

5098 POSTER Prognostic Factors of Breast Cancer Brain Metastases

A randomized controlled phase II trial of a novel composition of paclitaxel embedded into neutral and cationic lipids targeting tumor endothelial cells in advanced triple-negative breast cancer (TNBC)

Endocrine therapy or chemotherapy as first-line therapy in hormone receptor–positive HER2-negative metastatic breast cancer patients

Expression of the hypoxia-inducible monocarboxylate transporter MCT4 is increased in triple negative breast cancer and correlates independently with clinical outcome

Paclitaxel plus bevacizumab or paclitaxel as first-line treatment for HER2-negative metastatic breast cancer in a multicenter national observational study

Local Recurrence after Breast Cancer Affects Survival Differently According to Patient Age

Epidermal growth factor receptor expression in 780 breast cancer patients: A reappraisal of the prognostic value based on an eight-year median follow-up

What do you think about generic drugs products? Results from a survey

Corrigendum to “De novo metastatic breast cancer in patients with a small locoregional tumour (T1-T2/N0): characteristics and prognosis” [Eur J Cancer 158 (2021) 181–188]

De novo metastatic breast cancer in patients with a small locoregional tumour (T1-T2/N0): Characteristics and prognosis

Radio-frequency heating of the cornea: theoretical model and in vitro experiments

Stereotactic Pelvic Reirradiation for Locoregional Cancer Relapse

A personalized adjuvant treatment for women over 70 presenting with a luminal breast cancer? ASTER 70s or an ongoing phase III trial with parallel cohort by the UNICANCER GERICO and UCBG groups for an ongoing question

Breast cancer patients treated with intrathecal therapy for leptomeningeal metastases in a large real-life database

Incidence and outcome of brain and/or leptomeningeal metastases in HER2-low metastatic breast cancer in the French ESME cohort

430 Dose finding of inecalcitol, a new VDR agonist, in combination with docetaxel–prednisone regimen for castrate-resistant prostate cancer (HRPC) patients (pts)

Outcomes of 9800 metastatic luminal HER2-negative breast cancer patients in the French national real-life UNICANCER ESME-breast cohort

102 (PB-003) - Outcomes of 9800 metastatic luminal HER2-negative breast cancer patients in the French national real-life UNICANCER ESME-breast cohort

Patritumab deruxtecan in untreated hormone receptor-positive/HER2-negative early breast cancer: final results from part A of the window-of-opportunity SOLTI TOT-HER3 pre-operative study

Suchergebnisse filtern